[{"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Alcon Laboratories Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "TX", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005405", "Total_Amount_of_Payment_USDollars": "33.60", "Date_of_Payment": "07/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "167488267", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "25.81", "Date_of_Payment": "09/29/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156819164", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Invega Sustenna", "Name_of_Associated_Covered_Drug_or_Biological2": "Risperdal Consta", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Phadia US Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MI", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010419", "Total_Amount_of_Payment_USDollars": "24.04", "Date_of_Payment": "10/03/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "132840204", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "23.21", "Date_of_Payment": "10/27/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156819166", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Risperdal Consta", "Name_of_Associated_Covered_Drug_or_Biological2": "Invega Sustenna", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "21.61", "Date_of_Payment": "12/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "301057868", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VYVANSE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "19.17", "Date_of_Payment": "09/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300655654", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VYVANSE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "17.81", "Date_of_Payment": "08/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300655648", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VYVANSE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sanofi Pasteur Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000299", "Total_Amount_of_Payment_USDollars": "17.30", "Date_of_Payment": "11/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "182407533", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MENACTRA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTACEL", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "17.02", "Date_of_Payment": "05/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "206553526", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "QUILLIVANT XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI PASTEUR INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000299", "Total_Amount_of_Payment_USDollars": "16.82", "Date_of_Payment": "04/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "319235612", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MENACTRA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTACEL", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "16.27", "Date_of_Payment": "11/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "206766262", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "QUILLIVANT XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "MedImmune, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MD", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000169", "Total_Amount_of_Payment_USDollars": "16.25", "Date_of_Payment": "09/16/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "10856833", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SYNAGIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "15.96", "Date_of_Payment": "08/27/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "206792844", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "QUILLIVANT XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "15.28", "Date_of_Payment": "09/20/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "14262816", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AUVIQ", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "14.70", "Date_of_Payment": "01/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323817286", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "QUILLIVANT XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "13.96", "Date_of_Payment": "11/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "301057862", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VYVANSE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "13.77", "Date_of_Payment": "12/12/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "205180534", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "QUILLIVANT XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "13.75", "Date_of_Payment": "08/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300655640", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VYVANSE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "LILLY USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "13.53", "Date_of_Payment": "11/22/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "4716138", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "STRATTERA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "13.36", "Date_of_Payment": "05/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300256246", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VYVANSE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "12.79", "Date_of_Payment": "04/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322471442", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "QUILLIVANT XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "12.62", "Date_of_Payment": "09/04/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "205200818", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "QUILLIVANT XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "MedImmune, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MD", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000169", "Total_Amount_of_Payment_USDollars": "12.54", "Date_of_Payment": "09/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260044974", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FLUMIST DOM  QLAIV", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "12.37", "Date_of_Payment": "03/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "207206736", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "QUILLIVANT XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "12.00", "Date_of_Payment": "06/13/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136391004", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "INTUNIV", "Name_of_Associated_Covered_Drug_or_Biological2": "VYVANSE", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "11.99", "Date_of_Payment": "04/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300256234", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VYVANSE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Mylan Specialty L.P.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "WV", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005573", "Total_Amount_of_Payment_USDollars": "11.89", "Date_of_Payment": "08/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "186094002", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EpiPen", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "11.46", "Date_of_Payment": "09/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323982922", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PREVNAR - 13", "Name_of_Associated_Covered_Drug_or_Biological2": "TRUMENBA", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "11.13", "Date_of_Payment": "08/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "268142624", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "STRATTERA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "11.10", "Date_of_Payment": "09/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "268142626", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "STRATTERA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "10.75", "Date_of_Payment": "03/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "299159144", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VYVANSE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "10.59", "Date_of_Payment": "10/16/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "205562126", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "QUILLIVANT XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Mylan Specialty L.P.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "WV", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005573", "Total_Amount_of_Payment_USDollars": "10.48", "Date_of_Payment": "06/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "320280206", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EpiPen", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "10.44", "Date_of_Payment": "06/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300256256", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VYVANSE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "2.55", "Date_of_Payment": "09/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302206638", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VYVANSE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.73", "Date_of_Payment": "05/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302190760", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VYVANSE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "646714", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.65", "Date_of_Payment": "09/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302208496", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VYVANSE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}]